©The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Role of autophagy in bone and muscle biology
Maria Teresa Valenti, Luca Dalle Carbonare, Department of Medicine, Section of Internal Medicine D, University of Verona, 37134 Verona, Italy
Monica Mottes, Department of Neurological, Biomedical and Movement Sciences, Section of Biology and Genetics, University of Verona, 37134 Verona, Italy
Author contributions: All authors contributed equally to the preparation of the manuscript.
Conflict-of-interest statement: All authors disclose no financial and personal relationships with other people or organizations that could inappropriately influence or bias their work.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Maria Teresa Valenti, PhD, Department of Medicine, Section of Internal Medicine D, University of Verona, Piazzale Scuro, 10, 37134 Verona, Italy. firstname.lastname@example.org
Telephone: +39-045-8128450 Fax: +39-045-8027496
Received: June 1, 2016
Peer-review started: June 3, 2016
First decision: July 5, 2016
Revised: July 26, 2016
Accepted: September 21, 2016
Article in press: September 22, 2016
Published online: December 26, 2016
Autophagy is a key process in cellular homeostasis and is involved in removing and recycling misfolded proteins, damaged organelles or dysfunctional cell components. Autophagy may be distinguished into the following three categories: (1) macroautophagy; (2) microautophagy; and (3) chaperone-mediated autophagy[1,2]. Macroautophagy is the most prevalent form of autophagy among different cell types[3,4]. It starts with the formation of a phagophore, which is a membrane protrusion that expands to engulf the cellular cargo, generating an autophagosome. This latter structure matures via fusion with lysosomes. TOR kinase is a major player in autophagy and acts as a signalling node downstream of growth factor receptor signalling, hypoxia, changes in ATP levels and insulin signalling. It is activated downstream of Akt kinase, PI3-kinase and growth factor receptors and acts to inhibit autophagy by modulating the Ulk1 (Atg1) complex. In response to autophagy cascade activation, the class III PI3K complex produces PI(3)P and induces other Atg proteins, including Atg12-Atg5-Atg16, as well as the LC3 (Atg8)-phosphatidylethanolamine complex. LC3 is the commonly used term for microtubule-associated protein 1 light chain 3. After translation, proLC3 is proteolytically cleaved by Atg4 protease, which generates LC3-I. Upon induction of autophagy, LC3-I is conjugated to the highly lipophilic phosphatidylethanolamine (PE) moiety by the Atg7, Atg3 and Atg12-Atg5-Atg16L complex to generate LC3-II. Finally, PE promotes the integration of LC3-II into lipid membranes to promote autophagosome formation.
Mice lacking Atg7, which is a specific liver gene for autophagosome formation, developed severe hepatomegaly as a consequence of intracellular accumulation of aggregates and non-functional organelles. Furthermore, knockout mice bearing a neural-specific deletion of either Atg7 or Atg5, both of which are required for autophagosome formation, developed ataxic gait, abnormal motor coordination and systemic tremor[3,4]. In addition to recycling amino acids after protein degradation, autophagy may also contribute to energy production through the generation of free fatty acids.
Recent studies have shown that autophagy might play different roles depending on the cellular context, leading to either apoptosis or survival by modulating key genes.
In addition, perturbations of the autophagy machinery have been linked to different disorders such as ischaemic cardiomyopathy and neurodegenerative diseases[8,9].
AUTOPHAGY IN BONE BIOLOGY
Osteoblasts, the bone-forming cells, secrete the skeletal matrix (osteoid) and have a principal role in bone mineralization. During differentiation, the osteoblast assumes the characteristics of an osteocyte, which orchestrates bone remodelling. At present, 2 families of transcription factors involved in the autophagy process, the forkhead box O (FOXO) and cAMP responsive element binding protein (CREB) families, are known to regulate osteoblasts. FOXO activation promotes autophagy by binding to the promoter regions of target genes, and studies have shown that deletion of FOXO genes causes oxidative stress and apoptosis. Conversely, overexpression of FOXO3 reduces bone impairment associated with ageing. The involvement of FOXO genes in the regulation of bone homeostasis may conceivably be due, at least in part, to the induction of autophagy. ATF4 (a member of the CREB family) is required to support osteoblast function and maturation as well as to reduce cellular stress due to amino acid starvation because it increases amino acid trafficking into cells. Reduced ATF4 activity has been associated with skeletal impairments such as Coffin-Lowry syndrome and neurofibromatosis type I. Another autophagy protein involved in osteoblast biology is the autophagy receptor NBR1 (a neighbour of BRCA1 gene 1), which interacts with the MAP1LC3 protein family through its LC3-interacting region. Autophagy is also involved in osteoclastogenesis. The autophagy proteins Atg5, Atg7, Atg4B and MAP1LC3 are required for osteoclast differentiation; these cells are responsible for bone resorption. Among others, Atg5 and Atg7 promote bone remodelling by inducing bone resorption via directing lysosomes through the plasma membrane into the extracellular space.
AUTOPHAGY IN MUSCLE
Autophagy plays a crucial role in muscle cells under both healthy and adverse conditions. The highly structured organization of skeletal muscle cells and their function may cause damage to proteins and organelles; mitochondria are particularly susceptible because of the increased generation of reactive oxygen species compared to other tissues. Muscle cells therefore require efficient housekeeping mechanisms that can quickly eliminate unfolded and toxic proteins as well as dysfunctional organelles. Under physiological conditions, basal levels of autophagy guarantee muscle cell homeostasis, whereas upregulation of the autophagic machinery contributes to cell survival under various stress conditions, including calorie restriction (CR), atrophy, and sarcopenia, by maintaining the required amino acid supply and metabolite levels.
AUTOPHAGY AND PHYSICAL EXERCISE
A chaperone-assisted selective autophagy process (CASA) has been characterized as a tension-induced autophagy pathway essential for the adaptation of mechanically strained tissues such as skeletal muscle, heart, lung and kidney. In striated skeletal muscle, the CASA machinery is located at the Z-disk; this is of critical importance because the complex mediates the degradation of large cytoskeleton components (e.g., FLNC, filamin C) damaged during contraction. Recent studies demonstrated that strenuous resistance exercise caused a significant increase in CASA activity in muscles of healthy men who trained moderately. Impairment of CASA in animal models, however, leads to muscle weakness.
AUTOPHAGY AND MUSCLE DISORDERS
The hallmark of autophagy, autophagosomes, are found in most myopathies and dystrophies. In many acquired and genetic muscle diseases, however, misregulation rather than upregulation of autophagic and protein degradation machineries appear to be the cause of muscle degeneration.
AUTOPHAGY AND AGEING
Sarcopenia, which is ageing-related skeletal muscle loss, is a common debilitating condition affecting 5%-13% of the elderly population over 60. Imbalance between protein synthesis and protein degradation; the accumulation of denatured, misfolded or aggregated molecules; mitochondrial dysfunction; and excessive apoptosis caused by complex intrinsic and extrinsic factors can result in sarcopenia. Growing molecular evidence supports the idea that dysregulated autophagy may contribute to sarcopenia. Strategies (e.g., CR and life-long exercise) aiming to induce an appropriate autophagic process in muscle cells may reduce age-associated muscle wasting. Autophagy is therefore a potential target for sarcopenia; bioactive molecules known to modulate autophagy can play a beneficial role at the cellular level in the ageing process.
It is not surprising that bone and muscle structures and functions are tightly regulated by endogenous and environmental factors. Autophagy plays a relevant role in physiological and pathological conditions: A well-balanced performance of the autophagic machinery is essential for both bone and muscle homeostasis. Thus, in-depth knowledge of autophagy may provide new molecular targets for maintaining bone and muscle formation and metabolism to assure a good quality of life.
Manuscript source: Invited manuscript
Specialty type: Cell and tissue engineering
Country of origin: Italy
Peer-review report classification
Grade A (Excellent): 0
Grade B (Very good): B
Grade C (Good): C
Grade D (Fair): 0
Grade E (Poor): 0
P- Reviewer: Liu L, Liu SH S- Editor: Kong JX L- Editor: A E- Editor: Li D